Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001699 · ClinicalTrials.gov registry record

A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
45
Enrollment target

NCT00001699: Completed study, sponsored by National Cancer Institute (NCI).

NCT00001699 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00001699 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

The proposed study has two specific aims 1) to gather data about treatment adherence levels among adolescents (11-21 years) with HIV and 2) to obtain information about the adolescents and mothers' health beliefs and examine their relationship to the adolescents' adherence levels. This pilot study is designed to gather preliminary data about the feasibility of using several new measures with this population. To achieve these aims, a convenience sample of approximately 45 adolescents with HIV will re recruited. The adolescents and their mothers will complete a brief questionnaire about their health beliefs. A 24-hour recall interview format will be used to assess the adolescents' treatment adherence to prescribed oral medication. The adolescent will complete recall interviews on three random days over a two week period. Data analysis will be primarily descriptive, but will be used to generate more specific hypotheses for future research studies. The long-term goal of this research is to better identify adolescents with HIV at risk for non-adherence and design empirically derived interventions to improve their adherence levels. The health beliefs measure may also be useful in identifying irrational beliefs about the illness or treatment that can then be targeted for cognitive restructing in psychological interventions.

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 1998-06
Est. Completion 2000-03
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00001699 record still lists

NCT00001699 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00001699 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00001699 about?

NCT00001699 is a clinical study titled "A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers". The proposed study has two specific aims 1) to gather data about treatment adherence levels among adolescents (11-21 years) with HIV and 2) to obtain information about the adolescents and mothers' health beliefs and examine their relationship to the adolescents' adherence levels. This pilot study is...

What is the current status of trial NCT00001699?

This trial is currently completed. The enrollment target is 45 participants. The study started on 1998-06. Estimated completion is 2000-03.

Who is sponsoring clinical trial NCT00001699?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00001699, the US trial registry maintained by the National Library of Medicine. NCT00001699 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.